Patients with both Alzheimer’s and AFib may experience slower cognitive decline when treated with NOAC blood thinners. If you or a family member fall into this category, consult your cardiologist and neurologist to discuss whether transitioning to a NOAC is safe and appropriate given your specific health history and bleeding risk profile.
New research suggests that newer blood thinners, known as NOACs, may slow cognitive decline in Alzheimer’s patients who also have atrial fibrillation.